You are here: Home » News-CM » Companies » Results
Business Standard

Ajanta Pharma standalone net profit declines 23.20% in the June 2017 quarter

Capital Market 

Sales decline 4.77% to Rs 397.93 crore

Net profit of declined 23.20% to Rs 76.73 crore in the quarter ended June 2017 as against Rs 99.91 crore during the previous quarter ended June 2016. Sales declined 4.77% to Rs 397.93 crore in the quarter ended June 2017 as against Rs 417.87 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales397.93417.87 -5 OPM %27.6634.09 -PBDT114.73150.59 -24 PBT101.80138.16 -26 NP76.7399.91 -23

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU